Small cell lung cancerSEERCHEMOTHERAPYSURVIVALRESECTIONRADIOTHERAPYCARCINOMAPurpose The NCCN guidelines do not recommend surgery for T3-4N0M0/T1-4N1-2M0 small cell lung cancer (SCLC) due to a lack of evidence.Methods Data of patients with T3-4N0M0/T1-4N1-2M0 SCLC were extracted from the ...
Stage 2non-small cell lung cancer(NSCLC) is localized cancer that has not spread beyond one lung or the locallymph nodeson the same side of the chest. Any lung cancer diagnosis is serious, but being in thisearly stagemeans your disease is very treatable, and your chances for a long-term...
Thoracic Malignancy II: Beyond Non-small Cell Lung CancerSession ID: W6-CCH10Refresher CourseAMA PRA Category 1 Credit™: 1.00ARRT Category A+ Credits (In-person attendees only): 1.00LocationS402(Opens, 视频播放量 108、弹幕量 0、点赞数 0、投硬币枚数 0
This phase II trial aimed to evaluate S-1 in patients with relapsed small cell lung cancer (SCLC). SCLC patients who had experienced treatment failure with ≥1 prior chemotherapies were eligible. Patients were required to have an Eastern Cooperative Oncology Group (ECOG) performance status (PS)...
Patients with extensive-stage small cell lung cancer (ES-SCLC) who receive trilaciclib appear to experience lower rates of hematologic adverse effects than those who are not treated with the agent. November 15th 2023 What We’re Reading: Medicaid Coverage Errors; Gender Disparities in Health Resea...
Surgical treatment of the non-small cell lung cancer: Stage I (T1N0-T2N0) and stage II (T1N1-T2N1). Prognostic factors, results and recurrence - Lung Cancerdoi:10.1016/0169-5002(94)92245-4NoneLung Cancer
EORTC(European Organization for Research and Treatment of Cancer)的一项研究,将对化疗有反应的患者随机化分为2组,接受PCI或不接受PCI,发现PCI治疗组1年生存率为27.1%,未接受PCI者为13.3%。[49]在该研究中,PCI不仅减少脑转移的发生率也提高无病生存率和总体生存率。然而,欧洲肿瘤医学学会(ESMO)2010年的实践...
The 5-year survival of patients with small cell lung cancer is only 5%. The staging of small cell lung cancer is divided into limited stage and extensive stage (Box 64-3). Limited stage refers to disease that can be confined to one radiation port. At the time of presentation, ...
Small-cell lung cancer is a highly malignant form of lung cancer, also known as oat-cell carcinoma, that accounts for approximately 15% of lung cancer cases. Composed of small, ovoid cells with very little cytoplasm, small-cell lung cancer usually originates in the bronchi and is caused by...
In an ongoing, open-label, single-arm phase II study ( NCT02927301 ), 181 patients with untreated, resectable, stage IB–IIIB non-small cell lung cancer received two doses of neoadjuvant atezolizumab monotherapy. The primary end point was major pathologi